Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
John Farley(St. Joseph's Hospital), William E. Brady(Roswell Park Comprehensive Cancer Center), Vinod Vathipadiekal(Massachusetts General Hospital), Heather A. Lankes(Roswell Park Comprehensive Cancer Center), Robert L. Coleman(The University of Texas MD Anderson Cancer Center), Mark A. Morgan(Fox Chase Cancer Center), Robert S. Mannel(University of Oklahoma Health Sciences Center), S. Diane Yamada(University of Chicago), David G. Mutch(Washington University in St. Louis), William H. Rodgers(Lenox Hill Hospital), Michael J. Birrer(Massachusetts General Hospital), David M. Gershenson(The University of Texas MD Anderson Cancer Center)
Cited by 413
Abstract
Related Papers
No related papers found
Powered by citation graph analysis